Skip to main content
Veterinary Medicines

ZOODERMIN Vet Atb

Authorised
  • Zinc oxide
  • ICHTHAMMOL

Product identification

Medicine name:
ZOODERMIN Vet Atb
Active substance:
  • Zinc oxide
  • ICHTHAMMOL
Target species:
  • Horse
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Dog
  • Cat
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Zinc oxide
    150.00
    milligram(s)
    /
    1.00
    gram(s)
  • ICHTHAMMOL
    150.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Ointment
Withdrawal period by route of administration:
  • Cutaneous use
    • Horse
      • Meat and offal
        0
        day
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD04AX
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Antibiotice S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Antibiotice S.A.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 210157
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 8/11/2021
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."